← all signals · sectors · research

SANGAMO THERAPEUTICS, INC SGMO

SIC 2836 — Biological Products, (No Diagnostic Substances) · CIK 1001233

This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).

FY2021 short

2 signals fired · match: pair

capex_spike, fcf_turn_negative

HorizonPredicted net PnL
20 days+2.92%
60 days+1.26%
252 days (1y)-2.11%

FY2020 long

1 signal fired · match: singles_avg

fcf_turn_positive

HorizonPredicted net PnL
20 days+1.81%
60 days+4.48%
252 days (1y)+19.70%

FY2018 short

2 signals fired · match: pair

capex_spike, fcf_turn_negative

HorizonPredicted net PnL
20 days+2.92%
60 days+1.26%
252 days (1y)-2.11%

FY2017 short

2 signals fired · match: pair

capex_spike, fcf_turn_positive

HorizonPredicted net PnL
20 days+0.68%
60 days-5.04%
252 days (1y)-17.99%

FY2016 short

1 signal fired · match: singles_avg

dso_drift_severe

HorizonPredicted net PnL
20 days-2.54%
60 days-11.34%
252 days (1y)-24.65%

FY2015 short

1 signal fired · match: singles_avg

capex_spike

HorizonPredicted net PnL
20 days+2.05%
60 days-0.78%
252 days (1y)-14.91%

FY2011 short

2 signals fired · match: pair

capex_spike, dso_drift_severe

HorizonPredicted net PnL
20 days+2.99%
60 days-0.67%
252 days (1y)-33.05%

Methodology: /methodology · Live JSON: /api/company/1001233/financials